相似文献
1
Tolperisone: a typical representative of a class of centrally acting muscle relaxants with less sedative side effects.
CNS Neurosci Ther. 2008 Summer;14(2):107-19. doi: 10.1111/j.1527-3458.2008.00044.x.
2
Tolperisone.
J Assoc Physicians India. 2010 Feb;58:127-8.
3
[Mydeton: a centrally acting muscle relaxant drug from Gedeon Richter LTD].
Acta Pharm Hung. 2002;72(1):49-61.
4
Prophylactic tolperisone for post-exercise muscle soreness causes reduced isometric force--a double-blind randomized crossover control study.
Eur J Pain. 2003;7(5):407-18. doi: 10.1016/S1090-3801(02)00145-3.
5
6
An assessment of the centrally acting muscle relaxant tolperisone on driving ability and cognitive effects compared to placebo and cyclobenzaprine.
J Clin Pharm Ther. 2020 Aug;45(4):774-782. doi: 10.1111/jcpt.13165. Epub 2020 May 10.
7
Identification of metabolic pathways involved in the biotransformation of tolperisone by human microsomal enzymes.
Drug Metab Dispos. 2003 May;31(5):631-6. doi: 10.1124/dmd.31.5.631.
8
Effects of centrally acting muscle relaxants on post-rotatory nystagmus in the rabbit.
Gen Pharmacol. 1989;20(1):47-51. doi: 10.1016/0306-3623(89)90059-1.
9
Evaluation of sedative effects of single and repeated doses of 50 mg and 150 mg tolperisone hydrochloride. Results of a prospective, randomized, double-blind, placebo-controlled trial.
Pharmacopsychiatry. 1998 Jul;31(4):137-42. doi: 10.1055/s-2007-979315.
10
Anaphylactic reactions to tolperisone (Mydocalm).
Swiss Med Wkly. 2003 Jun 28;133(25-26):369-71. doi: 10.4414/smw.2003.10280.
引用本文的文献
1
1,2-Redox Transpositions of Tertiary Amides.
J Am Chem Soc. 2023 Oct 11;145(40):21745-21751. doi: 10.1021/jacs.3c08466. Epub 2023 Sep 27.
2
Sustainable Removal of Tolperisone from Waters by Application of Photocatalysis, Nanotechnology, and Chemometrics: Quantification, Environmental Toxicity, and Degradation Optimization.
Nanomaterials (Basel). 2022 Nov 25;12(23):4199. doi: 10.3390/nano12234199.
3
Risk factors of anaphylaxis in Korea: Identifying drug-induced anaphylaxis culprits using big data.
Medicine (Baltimore). 2022 Sep 2;101(35):e30224. doi: 10.1097/MD.0000000000030224.
4
Antispasmodic Effect of Asperidine B, a Pyrrolidine Derivative, through Inhibition of L-Type Ca Channel in Rat Ileal Smooth Muscle.
Molecules. 2021 Sep 9;26(18):5492. doi: 10.3390/molecules26185492.
5
Efficacy and safety of tolperisone versus baclofen among Chinese patients with spasticity associated with spinal cord injury: a non-randomized retrospective study.
Braz J Med Biol Res. 2021 Sep 3;54(11):e11293. doi: 10.1590/1414-431X2021e11293. eCollection 2021.
6
X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease.
Science. 2021 May 7;372(6542):642-646. doi: 10.1126/science.abf7945. Epub 2021 Apr 2.
7
Tolperisone for the Treatment of Acute Muscle Spasm of the Back: Results from the Dose-Ranging Phase 2 STAR Study (NCT03802565).
J Pain Res. 2020 Nov 23;13:3059-3069. doi: 10.2147/JPR.S278857. eCollection 2020.
8
The comparative study of clinical efficacy and safety of baclofen vs tolperisone in spasticity caused by spinal cord injury.
Saudi Pharm J. 2017 May;25(4):655-659. doi: 10.1016/j.jsps.2017.04.041. Epub 2017 May 7.
9
Influence of CYP2D6 and CYP2C19 genetic polymorphism on the pharmacokinetics of tolperisone in healthy volunteers.
Eur J Clin Pharmacol. 2015 Jun;71(6):699-705. doi: 10.1007/s00228-015-1856-5. Epub 2015 May 9.
10
Basic aspects of the pharmacodynamics of tolperisone, a widely applicable centrally acting muscle relaxant.
Open Med Chem J. 2014 Jul 11;8:17-22. doi: 10.2174/1874104501408010017. eCollection 2014.
本文引用的文献
1
Considerable interindividual variation in the pharmacokinetics of tolperisone HCl.
Int J Clin Pharmacol Ther. 2007 Feb;45(2):110-3. doi: 10.5414/cpp45110.
2
Silperisone: a centrally acting muscle relaxant.
CNS Drug Rev. 2006 Fall-Winter;12(3-4):218-35. doi: 10.1111/j.1527-3458.2006.00218.x.
3
[Comparative effciency of bakloferon and tolperizon central muscle relaxants in complex therapy of back pain].
Voen Med Zh. 2006 Sep;327(9):52-5.
4
Gas-liquid chromatographic method for the determination of tolperisone in human plasma: pharmacokinetic and comparative bioavailability studies.
J Pharm Biomed Anal. 1987;5(7):695-700. doi: 10.1016/0731-7085(87)80082-1.
5
HPLC determination of tolperisone in human plasma.
Arch Pharm Res. 2006 Apr;29(4):339-42. doi: 10.1007/BF02968581.
6
A comparative study of the action of tolperisone on seven different voltage dependent sodium channel isoforms.
Eur J Pharmacol. 2006 May 24;538(1-3):5-14. doi: 10.1016/j.ejphar.2006.03.034. Epub 2006 Mar 21.
7
[A randomized, double blind, placebo-controlled study of the efficacy and safety of tolperisone in spasticity following cerebral stroke].
Zh Nevrol Psikhiatr Im S S Korsakova. 2006;106(1):34-42.
8
[A study of mydocalm efficiency in the treatment of chronic headache of tension].
Zh Nevrol Psikhiatr Im S S Korsakova. 2005;105(12):13-7.
9
[Midocalm in complex therapy of chronic low back pain syndrome].
Klin Med (Mosk). 2005;83(11):45-9.
10
Tolperisone-type drugs inhibit spinal reflexes via blockade of voltage-gated sodium and calcium channels.
J Pharmacol Exp Ther. 2005 Dec;315(3):1237-46. doi: 10.1124/jpet.105.089805. Epub 2005 Aug 26.
Zotero 插件